Clinical Trial Update: A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of KCT-0809 in dry eye syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• KCT-0809

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Dry Eye Syndromes | Phase 2 | Status: COMPLETED